Clinical Trial Update: Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lisdexamfetamine dimesylate with atomoxetine in ADHD patients with inadequate response to methylphenidate; results posted after completi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)
• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

Sponsor: Shire | Conditions: Attention-Deficit/Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-06-24